Top

Langenbeck's Archives of Surgery

Published in:

01-02-2012 | Original Article

Minimally invasive cortical-sparing surgery for bilateral pheochromocytomas

Authors: Pier Francesco Alesina, Jakob Hinrichs, Beate Meier, Kurt W. Schmid, Hartmut P. H. Neumann, Martin K. Walz

Published in: Langenbeck's Archives of Surgery | Issue 2/2012

Abstract

Introduction

Cortical-sparing adrenalectomy in bilateral pheochromocytomas offers a postoperative corticoid-free course and has to be balanced against the risk of local recurrence. In this study we report our experience with the minimally invasive cortical-sparing adrenalectomy in patients with bilateral pheochromocytomas.

Methods

From January 1996 to February 2011, 66 patients (45 men, 21 women; mean age 36 ± 16 years) were treated for bilateral pheochromocytomas. Fifty-seven patients (88%) were affected by genetic diseases. In 32 patients surgery was synchronously performed on both side, in 34 cases adrenalectomy followed previous surgery. All in all, 101 operations (47 right, 54 left) were conducted using the retroperitoneoscopic access (n = 97) or the laparoscopic route (n = 4).

Results

The mortality in our series was zero. Postoperative complications included one patient with a bleeding requiring reoperation and one patient developing a cerebral stroke on the fifth postoperative day. The mean operative time was 67 ± 26 min for unilateral adrenalectomy and 128 ± 68 min for bilateral surgery (range 25–300 min). A cortical-sparing resection was possible in 89 procedures resulting in a corticoid-free postoperative course in 60 patients (91%). A postoperative corticosteroid substitution therapy was necessary in six patients. During a median follow-up period of 48 months, one patient showed a persistent disease and needed reoperation, none developed a recurrent disease.

Conclusion

Cortical-sparing surgery for bilateral pheochromocytomas has a low recurrence rate and avoids lifelong cortisone substitution therapy in the majority of cases.

Manger WM (2006) An overview of pheochromocytoma: history, current concepts, vagaries, and diagnostic challenges. Ann N Y Acad Sci 1073:1–20PubMedCrossRef

Neumann HP, Vortmeyer A, Schmidt D, Werner M, Erlic Z, Cascon A, Bausch B, Januszewicz A, Eng C (2007) Evidence of MEN-2 in the original description of classic pheochromocytoma. N Engl J Med 357:1311–1315PubMedCrossRef

Neumann HP, Bausch B, Mcwhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K, Januszewicz A, Eng C, Smith WM, Munk R, Manz T, Glaesker S, Apel TW, Treier M, Reineke M, Walz MK, Hoang-Vu C, Brauckhoff M, Klein-Franke A, Klose P, Schmidt H, Maier-Woelfle M, Peczkowska M, Szmigielski C (2002) Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346:1459–1466PubMedCrossRef

Petri BJ, Van Eijck CH, De Herder WW, Wagner A, De Krijger RR (2009) Phaeochromocytomas and sympathetic paragangliomas. Br J Surg 96:1381–1392PubMedCrossRef

Gates FL (1918) Antibody production after partial adrenalectomy in guinea pigs. J Exp Med 27:725–738PubMedCrossRef

Decourcy JL (1934) Subtotal bilateral adrenalectomy for hyperadrenalism (essential hypertension). Ann Surg 100:310–318PubMedCrossRef

Broster LR (1948) Adrenal virilism (group I) bilateral partial adrenalectomy. Proc R Soc Med 41:196PubMed

Giordano WC (1982) Preservation of adrenocortical function during surgery for bilateral pheochromocytoma. J Urol 127:100–102PubMed

Irvin GL 3rd, Fishman LM, Sher JA (1983) Familial pheochromocytoma. Surgery 94:938–940PubMed

10.

Lairmore TC, Ball DW, Baylin SB, Wells S Jr (1993) Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes. Ann Surg 217:595–601PubMedCrossRef

11.

Asari R, Scheuba C, Kaczirek K, Niederle B (2006) Estimated risk of pheochromocytoma recurrence after adrenal-sparing surgery in patients with multiple endocrine neoplasia type 2A. Arch Surg 141:1199–1205, discussion 1205PubMedCrossRef

12.

Walz MK (2004) Extent of adrenalectomy for adrenal neoplasm: cortical sparing (subtotal) versus total adrenalectomy. Surg Clin North Am 84:743–753PubMedCrossRef

13.

Walz MK, Peitgen K, Hoermann R, Giebler RM, Mann K, Eigler FW (1996) Posterior retroperitoneoscopy as a new minimally invasive approach for adrenalectomy: results of 30 adrenalectomies in 27 patients. World J Surg 20:769–774PubMedCrossRef

14.

Walz MK, Peitgen K, Saller B, Giebler RM, Lederbogen S, Nimtz K, Mann K, Eigler FW (1998) Subtotal adrenalectomy by the posterior retroperitoneoscopic approach. World J Surg 22:621–626, discussion 626–627PubMedCrossRef

15.

Walz MK, Alesina PF, Wenger FA, Koch JA, Neumann HP, Petersenn S, Schmid KW, Mann K (2006) Laparoscopic and retroperitoneoscopic treatment of pheochromocytomas and retroperitoneal paragangliomas: results of 161 tumors in 126 patients. World J Surg 30:899–908PubMedCrossRef

16.

Walz MK, Gwosdz R, Levin SL, Alesina PF, Suttorp AC, Metz KA, Wenger FA, Petersenn S, Mann K, Schmid KW (2008) Retroperitoneoscopic adrenalectomy in Conn's syndrome caused by adrenal adenomas or nodular hyperplasia. World J Surg 32:847–853PubMedCrossRef

17.

Alesina PF, Hommeltenberg S, Meier B, Petersenn S, Lahner H, Schmid KW, Mann K, Walz MK (2010) Posterior retroperitoneoscopic adrenalectomy for clinical and subclinical Cushing's syndrome. World J Surg 34:1391–1397PubMedCrossRef

18.

Walz MK, Alesina PF, Wenger FA, Deligiannis A, Szuczik E, Petersenn S, Ommer A, Groeben H, Peitgen K, Janssen OE, Philipp T, Neumann HP, Schmid KW, Mann K (2006) Posterior retroperitoneoscopic adrenalectomy—results of 560 procedures in 520 patients. Surgery 140:943–948, discussion 948–950PubMedCrossRef

19.

Walz MK, Alesina PF (2009) Single access retroperitoneoscopic adrenalectomy (SARA)—one step beyond in endocrine surgery. Langenbecks Arch Surg 394:447–450PubMedCrossRef

20.

Brauckhoff M, Thanh PN, Gimm O, Bar A, Brauckhoff K, Dralle H (2003) Functional results after endoscopic subtotal cortical-sparing adrenalectomy. Surg Today 33:342–348PubMedCrossRef

21.

Parnaby CN, Galbraith N, O'dwyer PJ (2010) Importance of the adrenal gland blood supply during laparoscopic subtotal adrenalectomy. J Laparoendosc Adv Surg Tech A 20:311–315PubMedCrossRef

22.

Walz MK, Peitgen K, Diesing D, Petersenn S, Janssen OE, Philipp T, Metz KA, Mann K, Schmid KW, Neumann HP (2004) Partial versus total adrenalectomy by the posterior retroperitoneoscopic approach: early and long-term results of 325 consecutive procedures in primary adrenal neoplasias. World J Surg 28:1323–1329PubMedCrossRef

23.

Neumann HP, Bender BU, Reincke M, Eggstein S, Laubenberger J, Kirste G (1999) Adrenal-sparing surgery for phaeochromocytoma. Br J Surg 86:94–97PubMedCrossRef

24.

Lee JE, Curley SA, Gagel RF, Evans DB, Hickey RC (1996) Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma. Surgery 120:1064–1070PubMedCrossRef

25.

Kiriakopoulos A, Economopoulos KP, Poulios E, Linos D (2011) Impact of posterior retroperitoneoscopic adrenalectomy in a tertiary care center: a paradigm shift. Surg Endosc. doi:10.1007/s00464-011-1762-6

26.

Walz MK, Groeben H, Alesina PF (2010) Single-access retroperitoneoscopic adrenalectomy (SARA) versus conventional retroperitoneoscopic adrenalectomy (CORA): a case–control study. World J Surg 34:1386–1390PubMedCrossRef

27.

Lombardi CP, Raffaelli M, De Crea C, Bellantone R, Fusco A, Bianchi A, Pontecorvi A, De Marinis L (2011) ACTH-dependent Cushing syndrome: the potential benefits of simultaneous bilateral posterior retroperitoneoscopic adrenalectomy. Surgery 149:299–300PubMedCrossRef

28.

Li ML, Fitzgerald PA, Price DC, Norton JA (2001) Iatrogenic pheochromocytomatosis: a previously unreported result of laparoscopic adrenalectomy. Surgery 130:1072–1077PubMedCrossRef

29.

Van Heerden JA, Sizemore GW, Carney JA, Grant CS, Remine WH, Sheps SG (1984) Surgical management of the adrenal glands in the multiple endocrine neoplasia type II syndrome. World J Surg 8:612–621PubMedCrossRef

30.

Albanese CT, Wiener ES (1993) Routine total bilateral adrenalectomy is not warranted in childhood familial pheochromocytoma. J Pediatr Surg 28:1248–1251PubMedCrossRef

31.

Walz MK (2009) Adrenalectomy for preservation of adrenocortical function. Indication and results. Chirurg 80:99–104PubMedCrossRef

32.

Jansson S, Khorram-Manesh A, Nilsson O, Kolby L, Tisell LE, Wangberg B, Ahlman H (2006) Treatment of bilateral pheochromocytoma and adrenal medullary hyperplasia. Ann N Y Acad Sci 1073:429–435PubMedCrossRef

33.

Brauckhoff M, Gimm O, Brauckhoff K, Dralle H (2004) Repeat adrenocortical-sparing adrenalectomy for recurrent hereditary pheochromocytoma. Surg Today 34:251–255PubMedCrossRef

Title: Minimally invasive cortical-sparing surgery for bilateral pheochromocytomas
Authors: Pier Francesco Alesina
Jakob Hinrichs
Beate Meier
Kurt W. Schmid
Hartmut P. H. Neumann
Martin K. Walz
Publication date: 01-02-2012
Publisher: Springer-Verlag
Published in: Langenbeck's Archives of Surgery / Issue 2/2012
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI: https://doi.org/10.1007/s00423-011-0851-2

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Minimally invasive cortical-sparing surgery for bilateral pheochromocytomas

Abstract

Introduction

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2012

Comparison of a lightweight polypropylene mesh (Optilene® LP) and a large-pore knitted PTFE mesh (GORE® INFINIT® mesh)—Biocompatibility in a standardized endoscopic extraperitoneal hernia model

Appendectomy and diagnosis-related groups (DRGs): patient classification and hospital reimbursement in 11 European countries

Malignant pheochromocytoma: new malignancy criteria

Surgical management of adrenal metastases

Positional statement of the European Society of Endocrine Surgeons (ESES) on malignant adrenal tumors

Adrenocortical carcinoma: effect of hospital volume on patient outcome